Intellectual property in marine biotech inventions

Introduction

Marine biotechnology involves the use of marine organisms, microorganisms, genetic materials, enzymes, algae and other biological resources for developing medicines, cosmetics, food products, industrial chemicals and environmental technologies. Marine organisms such as sponges, bacteria, seaweeds and marine fungi may contain valuable compounds with pharmaceutical and commercial applications.

Intellectual property (IP) protection plays an important role in encouraging research and investment in marine biotechnology. However, it also raises legal questions concerning ownership of marine genetic resources, patentability of naturally occurring substances, benefit-sharing with coastal communities and protection of traditional knowledge.

In India, these issues are governed primarily by the Patents Act, 1970, the Biological Diversity Act, 2002, the Environment (Protection) Act, 1986 and international agreements.

Patent protection for marine biotechnology inventions

Patents are the principal form of IP protection for marine biotech inventions. A patent may protect a genuinely new and inventive marine-derived product, manufacturing process, genetically modified microorganism or industrial application.

Under Section 2(1)(j) of the Patents Act, 1970, an invention must involve a new product or process, an inventive step and industrial applicability. However, not every discovery involving marine organisms is patentable.

Section 3(c) excludes the mere discovery of a living thing or non-living substance occurring in nature. Therefore, discovering a naturally existing marine enzyme or compound does not automatically create a patentable invention. A sufficiently inventive process of isolation, modification or application may qualify, depending on the claims and statutory requirements.

Section 3(d) may also restrict patents involving new forms of known substances unless the statutory requirements, including enhanced efficacy where applicable, are satisfied. Section 3(i) excludes certain methods of treatment and diagnosis of humans and animals.

For example, a researcher may discover a marine microorganism producing an antibiotic compound. The naturally occurring microorganism or compound may face patentability restrictions, whereas a genuinely inventive production process or modified composition may potentially qualify.

Protection of marine genetic resources and biodiversity

Marine genetic resources are valuable because they may contain biological properties useful for medical and industrial research. Their collection and commercial utilisation raise questions about access, ownership and equitable benefit-sharing.

The Biological Diversity Act, 2002 regulates access to biological resources occurring in India and associated knowledge. Its framework provides for approvals or other regulatory compliance, as applicable, for access, research, transfer of research results and commercial utilisation.

The 2023 amendment changed several provisions of the Act. Consequently, the applicable requirements must be examined according to the nature of the applicant, activity, resource and relevant rules.

The Convention on Biological Diversity, 1992 recognises national sovereignty over biological resources and promotes fair and equitable sharing of benefits arising from their utilisation. The Nagoya Protocol, 2010 further develops the framework for access and benefit-sharing.

Traditional knowledge and community rights

Traditional knowledge concerning marine organisms may be held by fishing communities, coastal populations and indigenous groups. Such knowledge may include the medicinal or commercial uses of seaweeds, marine plants and other biological resources.

Patent applications based on traditional knowledge can create disputes where applicants attempt to claim discoveries already known to local communities.

The Indian Traditional Knowledge Digital Library (TKDL) helps prevent wrongful patents by providing documented traditional knowledge to patent examiners. However, protection of marine traditional knowledge also requires proper documentation, community participation and fair benefit-sharing.

Copyright, trade secrets and other forms of protection

Marine biotechnology businesses may use several forms of IP protection beyond patents.

Copyright: May protect original scientific publications, research reports, software and original databases, but does not ordinarily protect scientific facts or biological discoveries themselves.

Trade secrets: Confidential laboratory methods, fermentation conditions, extraction techniques and manufacturing processes may be protected through confidentiality agreements and commercial arrangements.

Trademarks: May protect the names and commercial identities of marine-derived medicines, cosmetics and biotechnology products.

Industrial designs: May protect the visual appearance of certain product containers and equipment, where statutory requirements are met.

These rights can operate together, provided the relevant legal conditions are satisfied.

Important judicial decisions

1. Novartis AG v. Union of India (2013) 6 SCC 1

The Supreme Court examined the patentability of a modified pharmaceutical substance under Section 3(d) of the Patents Act. Although the case did not concern marine biotechnology, it established an important principle: minor modifications of known substances cannot automatically receive patent protection without satisfying statutory requirements.

This principle is relevant when marine-derived compounds are chemically modified before patent applications are filed.

2. Bishwanath Prasad Radhey Shyam v. Hindustan Metal Industries (1979) 2 SCC 511

The Supreme Court explained the importance of novelty and inventive step in patent law. A patent cannot be granted merely because an invention is new in a commercial sense; it must involve a genuine inventive contribution.

This principle is relevant to marine biotechnology inventions involving modified enzymes, extraction methods and biological manufacturing processes.

3. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019) 3 SCC 381

The Supreme Court considered patent-related disputes involving genetically modified seeds and biological technology. The decision demonstrates the complexity of applying patent law to inventions involving living organisms and biological processes.

Its principles may provide guidance in disputes involving genetically modified marine microorganisms and biotechnology products, although the judgment does not directly decide their patentability.

4. Merck Sharp and Dohme Corporation v. Glenmark Pharmaceuticals Ltd. (2015) 63 PTC 257 (Del)

The Delhi High Court examined pharmaceutical patent infringement and the protection available to patented inventions. The decision illustrates the importance of patent claims in determining infringement.

This principle is relevant where marine-derived pharmaceutical compounds are developed and commercialised under patent protection.

International legal framework

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) establishes minimum standards for patent protection. Article 27 generally requires patents to be available for inventions that satisfy the relevant conditions, subject to recognised exceptions.

The United Nations Convention on the Law of the Sea (UNCLOS) provides the broader legal framework for marine resources and maritime areas. The 2023 Agreement on Marine Biodiversity of Areas Beyond National Jurisdiction (BBNJ Agreement) addresses marine genetic resources, including questions of access and benefit-sharing. Its implementation and relationship with domestic IP laws remain important legal considerations.

Conclusion

Intellectual property protection in marine biotechnology encourages innovation, investment and commercial development of marine-derived products. However, patent rights must be balanced with biodiversity conservation, traditional knowledge protection and equitable benefit-sharing. Indian patent law, biodiversity legislation and international agreements collectively provide the foundation for regulating these inventions. A balanced framework is necessary to ensure that marine biological resources are developed responsibly while respecting the rights and interests of coastal communities and the public.